当前位置:
X-MOL 学术
›
J. Natl. Cancer Inst.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Corrigendum.
Journal of the National Cancer Institute ( IF 9.9 ) Pub Date : 2019-11-01 , DOI: 10.1093/jnci/djy199
Journal of the National Cancer Institute ( IF 9.9 ) Pub Date : 2019-11-01 , DOI: 10.1093/jnci/djy199
Corrigendum: CN Landen, Jr, C Lu, LY Han, KT Coffman, E Bruckheimer, et al. Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer JNCI J Natl Cancer Inst (2006) 98(21):1558-70.doi.org/10.1093/jnci/djj414.
中文翻译:
更正。
更正:CN Landen,Jr,C Lu,LY Han,KT Coffman,E Bruckheimer等。用激动抗体减少EphA2在卵巢癌中的功效和抗血管作用JNCI J Natl Cancer Inst(2006)98(21):1558-70。doi.org/10.1093/jnci/djj414。
更新日期:2019-01-25
中文翻译:
更正。
更正:CN Landen,Jr,C Lu,LY Han,KT Coffman,E Bruckheimer等。用激动抗体减少EphA2在卵巢癌中的功效和抗血管作用JNCI J Natl Cancer Inst(2006)98(21):1558-70。doi.org/10.1093/jnci/djj414。